Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,670 | 550 | 99.3% |
| Education | $60.65 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,169 | 50 | $0 (2019) |
| Novo Nordisk Inc | $622.33 | 37 | $0 (2019) |
| GlaxoSmithKline, LLC. | $598.72 | 37 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $513.58 | 37 | $0 (2024) |
| Lilly USA, LLC | $499.41 | 26 | $0 (2019) |
| Allergan Inc. | $460.30 | 38 | $0 (2019) |
| Amgen Inc. | $413.36 | 19 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $399.89 | 31 | $0 (2019) |
| PFIZER INC. | $381.51 | 29 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $377.10 | 27 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.74 | 1 | AstraZeneca Pharmaceuticals LP ($17.74) |
| 2019 | $1,764 | 104 | Boehringer Ingelheim Pharmaceuticals, Inc. ($290.57) |
| 2018 | $3,625 | 230 | Boehringer Ingelheim Pharmaceuticals, Inc. ($508.83) |
| 2017 | $3,324 | 219 | Boehringer Ingelheim Pharmaceuticals, Inc. ($369.25) |
All Payment Transactions
554 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Respiratory | ||||||
| 10/25/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardiology | ||||||
| 08/08/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Obesity | ||||||
| 08/08/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $0.33 | General |
| Category: Obesity | ||||||
| 08/07/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: DIABETES | ||||||
| 08/06/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/01/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Central Nervous System (CNS) | ||||||
| 07/31/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.34 | General |
| 07/30/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 07/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: DIABETES | ||||||
| 07/25/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes | ||||||
| 07/25/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE, LUCEMYRA | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2019 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/23/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Diabetes | ||||||
| 07/18/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 07/17/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/16/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: DIABETES | ||||||
| 07/12/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 522 | 709 | $160,506 | $58,717 |
| 2022 | 7 | 427 | 559 | $120,889 | $44,561 |
| 2021 | 8 | 236 | 259 | $49,484 | $17,402 |
| 2020 | 16 | 737 | 899 | $86,650 | $37,092 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 289 | $72,540 | $23,304 | 32.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 114 | 114 | $28,959 | $14,340 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 231 | $40,887 | $13,501 | 33.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 15 | $8,145 | $2,977 | 36.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,575 | $1,781 | 49.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,578 | $1,624 | 35.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 12 | 13 | $1,404 | $979.97 | 69.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 22 | $418.00 | $209.44 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 191 | $48,132 | $16,698 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 177 | $31,956 | $10,311 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 79 | 79 | $20,303 | $10,244 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $16,121 | $5,113 | 31.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $3,619 | $1,849 | 51.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 26 | 34 | $646.00 | $306.31 | 47.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 18 | $112.00 | $40.08 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 91 | $21,416 | $7,218 | 33.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $10,727 | $3,430 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 54 | $9,250 | $3,113 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 22 | 22 | $5,762 | $3,024 | 52.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 14 | 14 | $924.00 | $187.46 | 20.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 19 | 19 | $548.00 | $174.78 | 31.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 16 | 16 | $560.00 | $168.96 | 30.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 11 | 11 | $297.00 | $85.47 | 28.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 101 | 141 | $27,637 | $10,334 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 51 | 51 | $12,903 | $6,375 | 49.4% |
About Dr. Drew Edwards, M.D
Dr. Drew Edwards, M.D is a Family Medicine healthcare provider based in Bradenton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487744934.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Drew Edwards, M.D has received a total of $8,731 in payments from pharmaceutical and medical device companies, with $17.74 received in 2024. These payments were reported across 554 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,670).
As a Medicare-enrolled provider, Edwards has provided services to 1,922 Medicare beneficiaries, totaling 2,426 services with total Medicare billing of $157,772. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Bradenton, FL
- Active Since 10/13/2006
- Last Updated 05/01/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487744934
Products in Payments
- XIFAXAN (Drug) $525.76
- JARDIANCE (Drug) $489.00
- Trintellix (Drug) $453.32
- JANUVIA (Drug) $337.32
- SPIRIVA RESPIMAT (Drug) $335.82
- Victoza (Drug) $314.16
- XARELTO (Drug) $296.42
- Prolia (Biological) $294.54
- BREO (Drug) $247.99
- CHANTIX (Drug) $244.09
- TRULICITY (Drug) $226.42
- FARXIGA (Drug) $218.96
- SYMBICORT (Drug) $202.40
- VRAYLAR (Drug) $184.78
- REXULTI (Drug) $170.68
- STIOLTO RESPIMAT (Drug) $165.86
- ONZETRA Xsail (Drug) $161.08
- Ozempic (Drug) $160.92
- BYSTOLIC (Drug) $154.37
- TRADJENTA (Drug) $142.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bradenton
Dr. Jeremy Mcconnell, M.d, M.D
Family Medicine — Payments: $395,542
Dr. Azim Lalani, Md, MD
Family Medicine — Payments: $14,602
Ahmad Sahebzamani, Md, MD
Family Medicine — Payments: $12,480
Charles Timson, Md, MD
Family Medicine — Payments: $9,190
Dr. Audrey Lewerenz-Walsh, Do, DO
Family Medicine — Payments: $8,307
Karen Brainard, Md, MD
Family Medicine — Payments: $6,483